CT TAVR Abdomen Study
NCT: NCT05758701 · RECRUITING
Brief Summary
A standard polyenergetic CT (computed tomography) procedure utilizes 100 ml of iodinated contrast. A recent world-wide shortage of iodine based intravenous contrast has highlighted the need to search for alternative methods or doses. Reducing iodinated IV contrast dose can mitigate IV contrast supply shortages and enable significant cost savings for the radiology practice and hospital system. In addition, decreased IV contrast dose can potentially reduce the rate of acute kidney injury, specifically in patients with decreased renal function. The purpose of the study is to determine whether low IV contrast dose CT with monoenergetic reconstruction can be use for presurgical planning of transcatheter valve replacement (TAVR) procedure.
Frequently Asked Questions
What is CT TAVR Abdomen Study?
CT TAVR Abdomen Study is a clinical trial registered under NCT05758701. Current status: RECRUITING.
What is the status of NCT05758701?
The current status of NCT05758701 (CT TAVR Abdomen Study) is: RECRUITING.
When did CT TAVR Abdomen Study start?
CT TAVR Abdomen Study started on 2023-09-19.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.